Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTeresa Mateu Campos
About this trial
The goal of this study is to evaluate long term effects of focused extracorporeal shock wave therapy (fESWT) on triceps surae spasticity in stroke patients according to the number of sessions applied.
Hypothesis: 3 sessions of fESWT on equinus foot in stroke patients improve spasticity and functionality for longer term than 1 session of fESWT.
Eligibility criteria
Qualifiers
Age greater than 18 years old
Time from stroke (ischemic o hemorrhagic) onset of at least 6 months
Spastic equinus foot: triceps surae tone grade at least 1+ on the MAS score
Ability to walk alone with or without aids
Disqualifiers
Fixed ankle joint contracture
Severe medical problems
Treatment of the affected leg with botulinum toxin in the las 6 months
Cognitive impairment
Trial design
Treatments tested in this trial
- fESWT
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Teresa Mateu Campos
Lead sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Sponsor institution
Source ClinicalTrials.gov